Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

CLX PEER ANALYSIS

The Clorox Company — metric-by-metric comparison with peers and the industry median

CLXThe Clorox Company

🇺🇸 USA · US · Consumer Defensive · Household & Personal Products

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Household & Personal Products

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
CLXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
CLX-18.3%PUIG+2.6%BEI-26.7%ESSITY-B+10.5%HEN3+15.9%ULVR+0.8%
Year-to-Date (YTD)
CLX-1.1%PUIG+15.3%BEI-15.4%ESSITY-B+10.2%HEN3+12.4%ULVR-1.8%
1-Year
Split-adjusted
CLX-18.3%CHD+1.7%EL-0.1%ELF-38.4%IPAR-7.1%KVUE-1.0%
Year-to-Date (YTD)
CLX-1.1%CHD+18.8%EL-18.8%ELF-0.9%IPAR+46.5%KVUE+17.4%

Key Metric Comparison

P/E

Lower is better
CLX15.69PUIG8.71BEI18.20ESSITY-B15.42HEN315.12ULVR20.06Median 19.95

ROE

Higher is better
CLX—PUIG29.8%BEI11.0%ESSITY-B14.9%HEN39.6%ULVR33.4%Median 9.6%

Net Margin

Higher is better
CLX11.2%PUIG12.6%BEI9.5%ESSITY-B9.1%HEN39.9%ULVR11.9%Median 4.5%

Revenue Growth

Higher is better
CLX-3.7%PUIG44.5%BEI1.7%ESSITY-B-6.2%HEN3-5.1%ULVR-16.2%Median -3.6%

P/E

Lower is better
CLX15.69CHD32.14EL—ELF171.60IPAR23.13KVUE23.44Median 19.95

ROE

Higher is better
CLX—CHD16.8%EL-5.9%ELF2.8%IPAR20.3%KVUE15.7%Median 9.6%

Net Margin

Higher is better
CLX11.2%CHD11.8%EL-1.7%ELF1.6%IPAR11.3%KVUE10.6%Median 4.5%

Revenue Growth

Higher is better
CLX-3.7%CHD2.2%EL0.4%ELF24.6%IPAR1.9%KVUE-0.1%Median -3.6%

All Metrics

Valuation
MetricCLXPUIGBEIESSITY-BHEN3ULVRInd. Median
P/E15.698.71●18.2015.4215.1220.0619.95
P/B-177.06●2.481.992.191.507.722.64
EV/EBITDA11.576.28●8.848.688.6013.0213.05
P/S1.751.10●1.731.411.502.381.73
Financial Health
MetricCLXPUIGBEIESSITY-BHEN3ULVRInd. Median
Current Ratio0.841.121.90●1.051.190.791.22
Debt/Equity-6,695.5%●53.5%2.5%48.2%18.1%190.6%56.8%
NetDebt/EBITDA2.520.62-1.34●1.180.162.211.30
Profitability
MetricCLXPUIGBEIESSITY-BHEN3ULVRInd. Median
Net Margin11.2%12.6%●9.5%9.1%9.9%11.9%4.5%
ROE—29.8%11.0%14.9%9.6%33.4%●9.6%
ROA12.7%12.9%●7.1%7.1%5.9%8.0%3.9%
EBITDA Margin19.4%19.3%17.1%18.8%17.8%22.0%●17.3%
Growth + Dividend
MetricCLXPUIGBEIESSITY-BHEN3ULVRInd. Median
Rev. Growth-3.7%44.5%●1.7%-6.2%-5.1%-16.2%-3.6%
NI Growth8.9%54.1%●27.2%-0.8%1.4%-9.9%2.1%
Div. Yield5.1%●1.2%1.3%3.1%2.7%4.3%2.2%
Payout79.6%10.2%23.7%45.8%0.0%73.0%27.4%
Valuation
MetricCLXCHDELELFIPARKVUEInd. Median
P/E15.69●32.14—171.6023.1323.4419.95
P/B-177.06●5.637.733.994.443.582.64
EV/EBITDA11.57●19.6827.5932.0312.6114.3913.05
P/S1.75●3.802.082.762.622.491.73
Financial Health
MetricCLXCHDELELFIPARKVUEInd. Median
Current Ratio0.841.221.272.353.26●0.981.22
Debt/Equity-6,695.5%●56.8%232.9%81.1%20.7%81.6%56.8%
NetDebt/EBITDA2.521.454.603.91-0.18●2.391.30
Profitability
MetricCLXCHDELELFIPARKVUEInd. Median
Net Margin11.2%11.8%●-1.7%1.6%11.3%10.6%4.5%
ROE—16.8%-5.9%2.8%20.3%●15.7%9.6%
ROA12.7%●8.2%-1.3%1.4%11.3%6.1%3.9%
EBITDA Margin19.4%20.8%●9.0%9.8%20.5%20.7%17.3%
Growth + Dividend
MetricCLXCHDELELFIPARKVUEInd. Median
Rev. Growth-3.7%2.2%0.4%24.6%●1.9%-0.1%-3.6%
NI Growth8.9%26.9%—-76.5%2.1%53.6%●2.1%
Div. Yield5.1%●1.2%1.7%—2.8%4.3%2.2%
Payout79.6%39.2%-204.4%—60.7%146.2%27.4%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CLX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.